Pfizer Aktie
24,77 EUR -0,23 EUR -0,92 %
FSE
25,74 USD -0,03 USD -0,10 %
nachbörslichBTT
BTT
Werbung
Pfizer Rating
Pfizer Inc. Aktie Moody's Rating
A1
C
A3
Aaa
Investmentwürdig - Hohe Sicherheit
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
Investmentwürdig - Mittlere Sicherheit
Nicht als Investment geeignet
| Rating | A1 | Rating Typ Bank Financial Strength Rating Insurance Financial Strength Rating Enhanced Rating Insured Rating Long-Term Bank Deposit Rating Long-Term OSO Rating Long-Term Debt Rating Money Market Fund Rating Modeled Shadow Rating Management Quality Rating Probability of Default Rating Pfd/Pref Stock Rating Prospective Pfd/Pref Rating Short-Term Bank Deposit Rating Speculative Grade Liquidity Rating Prospective LT Debt Rating Short-Term Insurance Financial Strength Rating Short-Term OSO Rating Servicer Quality Short-Term Debt Rating Lloyd´s Syndicate Performance Rating Underlying Rating Unknown - for conversion use only | Long-Term Debt Rating |
| Letzte Aktion | AFF | Moody's Büro in | USA |
Anleihen von Pfizer Inc. mit Moody's Ratings
| Emittent | Anzahl Anleihen | Ratings |
|---|---|---|
| Pfizer Inc. | 16 | A1, A2 |